cvs revision mtf
TRANSCRIPT
-
7/25/2019 CVS Revision MTF
1/11
CVS REVISION
Topics: Bacteremia, SIRS & sepsis-relateddisorders/
Infective endocarditis.Block: Cardiovascular System C!S"
#BBS $ear % Semester Session '%/'%(
Lecturer-in-charge: MS
-
7/25/2019 CVS Revision MTF
2/11
%. T)e follo*in+ statements are TR/0S:
. SIRS is a systemic response *)ic) can1e due to isc)emia.
B. SIRS criteria includes leukocytosis and
a1normal 1ody temperature.C. Transient 1acteremia presents *it)
)i+) fever.
2. 3rimary #42S develops as a
conse5uence of SIRS.. 6roup B Streptococcus is t)e most
common cause of neonatal 1acteremia.
T
T
F
F
T
-
7/25/2019 CVS Revision MTF
3/11
. T)e follo*in+ statements are TR/0S:
. ndoto7in activates monocytes andmacrop)a+es.
B. Interleukinsare released 1y activated
macrop)a+es in SIRS.C. 3atients *)o )ave under+one
splenectomy are at increased risk ofenterococci disease.
2. Severe sepsis is de8ned as SIRS plus1acteremia.
. T)e 8rst indicator of septic s)ock inc)ildren is tac)ycardia.
T
T
F
F
T
-
7/25/2019 CVS Revision MTF
4/11
(. T)e follo*in+ statements are TR/0S:
. 3rimary viremia is associated *it))i+)er viral load.
B. T)e levels of anticoa+ulation factors
are increased in sepsis.C. T)e release of nitric o7ide from
endot)elial cells can lead to septics)ock.
2. Staphylococcus epidermidiscausesdevice-associated 1acteremia.
. Tetracycline is t)e dru+ of c)oice insepsis.
F
F
T
T
F
-
7/25/2019 CVS Revision MTF
5/11
9. T)e follo*in+ statements are TR/0S:
. Sta+e III of SIRS is de8ned 1y t)erelease of interlukines into t)ecirculation.
B. oradrenaline is a potent vasodialator.
C. Secondary #42S is due to direct insultof t)e causative microor+anism.
2. itric o7ide is a potent vasodialator.
. Penicillium marnefei ungemia is
commonly associated with intravenouscat)eters.
F
F
F
T
F
-
7/25/2019 CVS Revision MTF
6/11
;. T)e follo*in+ statements are TR/0S:
. disseminated intravascular coa+ulationis a complication of sepsis.
B. T)e term sepsis denotes SIRS *it)
R2S.
C. 3atients *it) sepsis usually su
-
7/25/2019 CVS Revision MTF
7/11
=. T)e follo*in+ statements are TR/0S:
. I!2 endocarditis is due to )i+)-pressure +radients and tur1ulent >o* .
B. m1oli formation is a complication ofinfective endocarditis.
C. arly prost)etic valve endocarditis isdue to endot)eliali?ation of sutures.
2. 3ulmonary valves are t)e mostcommon valves a
-
7/25/2019 CVS Revision MTF
8/11
@. T)e follo*in+ statements are TR/0S:
. Staphylococcus aureuscan infect onlynormal )eart valves.
B. Bartonellaspecies infective endocarditisis associated *it) ne+ative 1lood
cultures.C. Streptococcus is usually associated *it)
acute infective endocarditis.
2. I!2 infective endocarditis is usually
associated *it) )i+) +rade fever.. 3rost)etic valve endocarditis 3!" is
termed as early *)en t)e symptomsappear *it)in =' days of insertion.
F
T
F
T
T
-
7/25/2019 CVS Revision MTF
9/11
A. T)e follo*in+ statements are TR/0S:
. Staphylococcus aureus is t)e mostcommon causative a+ent of prost)eticvalve endocarditis.
B. C +roup is one of t)e causativea+ents of culture-ne+ativeendocarditis.
C. Dane*ay lesions are small, tendersu1cutaneous nodules on t)e pads oft)e 8n+ers or toes t)at last for only)ours or days.
2. Splinter )emorr)a+e is a clinicalpresentation of infective endocarditis.
. ever of more t)an (A is a maEor 2uke
T
F
T
F
T
-
7/25/2019 CVS Revision MTF
10/11
F. T)e follo*in+ statements are TR/0S:
. T)e treatment of prost)etic valvesinfective endocarditis is !ancomycinplus 6entamicin.
B. T)e ve+etation o
-
7/25/2019 CVS Revision MTF
11/11
%'. T)e follo*in+ statements are TR/0S:
. T)e prop)ylactic re+ime used for
moderate risk patients *)o *ill 1e)avin+ a +astrointestinal sur+ery isampicillin.
B. T)e treatment re+ime of infective
endocarditis is t)ree *eeks of )i+)dose anti1iotic.
C. nterococci infective endocarditis isusually nosocomial ac5uired infection.
2. I! !ancomycin *it) +entamycin areused for I!2 associated infectiveendocarditis.
. 3rop)yla7is for oral procedures is
directed mainly a+ainst streptococcus.
F
F
T
T
T